Various radiopharmaceuticals OPT YR 1
Ended Awarded Last action
- Contract number
- 36C24926N0017
- Awardee
-
Telix Pharmaceuticals US Inc. UEI NMRHMBK4YTH7
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $857,500
Award facts
- Contract value 100% obligated
- $857,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Fishers, IN 46037, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$500 | |
| Original award | $858,000 |
About this award
The Department of Veterans Affairs, Veterans Integrated Service Network 9 (VISN 9) has awarded Telix Pharmaceuticals US Inc. a Blanket Purchase Agreement (BPA) call order valued at $857.5K for the supply of various radiopharmaceuticals. The contract, effective October 1, 2025, with an ultimate completion date of September 30, 2026, operates as a firm fixed-price delivery order without small business set-aside designation. Telix Pharmaceuticals, headquartered in Fishers, Indiana, will perform the work at its Fishers location and will supply specialized radiopharmaceutical products for nuclear medicine and medical imaging services to support VA healthcare operations.
This award represents a continuation of Telix Pharmaceuticals' established relationship with the VA, leveraging the company's expertise in diagnostic and therapeutic radiopharmaceuticals, including products such as Illuccix for prostate cancer imaging. The BPA call order falls under the company's broader $4.394M blanket purchase agreement for various radiopharmaceuticals extending through September 2028, as well as its Federal Supply Schedule contracts under Schedule 65-I-B for drugs and pharmaceuticals. These contract vehicles enable VISN 9 medical centers to procure specialized nuclear medicine products through pre-negotiated pricing terms, supporting diagnostic and therapeutic imaging services across the veteran healthcare system.
Quick answers
Who was awarded contract 36C24926N0017?
36C24926N0017 was awarded to Telix Pharmaceuticals US Inc. by Veterans Integrated Service Network 9 (Veterans Health Administration) on October 1, 2025.
How much is contract 36C24926N0017 worth?
The government has obligated $857,500 on 36C24926N0017.
Is contract 36C24926N0017 an order under another contract?
Yes. 36C24926N0017 is a BPA call under 36F79722D0197-36C24924A0002, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24926N0017 competed?
The extent of competition for 36C24926N0017 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award